Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

“Identifying the causes and risk factors of MS and substantiating the effectiveness of certain interventions are both crucial ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

The damage can lead to both sudden “flares” of inflammation and a slow worsening of symptoms over time. Historically, MS has been broken down into specific subtypes, as detailed below. But the reality ...

Walker was 26 at the time that he was first diagnosed, and he was one of the brightest young stars in country music. Taste of ...

A recent study has identified a previously unreported risk factor for major depression. The lingering trauma of forced sex.

Explore how the Veteran Affairs (VA) MS Centers of Excellence enhance veteran care through a hub-and-spoke model, telehealth, and groundbreaking research.

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and ...

Zydus Lifesciences received USFDA approval for its Diroximel Fumarate capsules for multiple sclerosis, while concluding a ...

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

The ComSLI method uses simple tools to generate detailed images of brain nerve fibers and damage in neurological diseases, ...